Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Abbott Laboratories
(NY:
ABT
)
113.56
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Oct 1, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Abbott Laboratories
< Previous
1
2
...
14
15
16
17
18
19
20
21
22
...
38
39
Next >
Get a Dividend Every Month With These 3 Healthcare Stocks
March 01, 2023
With a little planning, you can receive a dependable dividend payout every month.
Via
The Motley Fool
Lucira Stock Jumps over 250% on FDA Approval, Beware Chapter 11
March 01, 2023
Lucira Health Inc. (NASDAQ: LHDX) shares spiked up 264% to close at $0.52 on a massive 278 million shares traded on the announcement of FDA approval for its
Via
MarketBeat
Topics
Initial Public Offering
Exposures
COVID-19
Product Safety
Securities Market
Why Abbott Laboratories Stock Bumped Higher Today
February 28, 2023
The company's specialized heart care products appear to prove their value in clinical testing.
Via
The Motley Fool
How Is The Market Feeling About Abbott Laboratories?
February 28, 2023
Abbott Laboratories's (NYSE:ABT) short percent of float has risen 11.43% since its last report. The company recently reported that it has 13.19 million shares sold short, which is 0.78% of all regular...
Via
Benzinga
Should Abbott and DexCom Investors Be Worried About Apple's Latest News?
February 28, 2023
The continuous glucose monitoring market could heat up.
Via
The Motley Fool
Why Cardiovascular Systems Stock Is Soaring Today
February 09, 2023
The medtech company has agreed to a buyout offer from Abbott Laboratories.
Via
The Motley Fool
Is This Dividend King a Buy for Income Investors?
February 07, 2023
This healthcare company has one of the most established payouts in its sector.
Via
The Motley Fool
Better Dividend Stock: Abbott Laboratories or Medtronic?
February 27, 2023
One of these top dividend stocks is a far more compelling buy today.
Via
The Motley Fool
Top 5 Health Care Stocks That May Rocket Higher In Q1 2023
February 27, 2023
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Via
Benzinga
Better Buy: Abbott Laboratories or DexCom Stock?
February 24, 2023
Both stocks should benefit from the growth in diabetes care.
Via
The Motley Fool
Why Abbott Laboratories Stock Sank Today
February 22, 2023
The company's glucose monitoring business might come under some serious pressure.
Via
The Motley Fool
What Does Apple Have To Do With DexCom Stock Trading Lower?
February 22, 2023
DexCom shares (NASDAQ: DXCM) are trading lower on Wednesday following a report that Apple Inc (NASDAQ: AAPL) is making progress on no-prick glucose tracking for its Watch.
Via
Benzinga
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: NUVASIVE (Nasdaq – NUVA), Oak Street Health (NYSE – OSH), Argo Group International Holdings, Ltd. (NYSE - ARGO), Cardiovascular Systems, Inc. (Nasdaq – CSII)
February 22, 2023
From
Brodsky & Smith LLC
Via
GlobeNewswire
3 Top Dividend Kings to Buy for the Long Haul
February 20, 2023
These companies have more than 150 years of dividend growth between them.
Via
The Motley Fool
2 Exceptional Growth Stocks Billionaires Keep Buying With Both Hands
February 20, 2023
A poor performance from the broad market didn't stop these billionaire hedge fund managers from placing big bets on three supercharged growth stocks.
Via
The Motley Fool
Interview With David Rolfe of Wedgewood Partners
February 17, 2023
Motley Fool analyst John Rotonti recently seized the opportunity to interview David Rolfe.
Via
The Motley Fool
I ‘Tricked’ ChatGPT Into Picking Stocks to Buy. Here’s What It Said.
February 17, 2023
We asked ChatGPT to name various types of stocks to buy. Can the latest artificial intelligence craze get things right?
Via
InvestorPlace
How Abbott Labs, AbbVie Could Profit on Seizure Drug Formula
February 17, 2023
New research suggests Depakote ingredient could have a new clinical function. This could present more profit potential for drugmakers as well as investors.
Via
MarketBeat
7 Hot Healthcare Stocks With the Potential to Outperform
February 15, 2023
These healthcare stocks to buy now have the potential to outperform the market over the long-term because their businesses are strong.
Via
InvestorPlace
Which Healthcare Stock Is a Better Pick in 2023?
February 14, 2023
With a potential recession on the horizon, healthcare stocks could be good picks for investors. Which of these three is best?
Via
InvestorPlace
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: NUVASIVE (Nasdaq – NUVA), Oak Street Health (NYSE – OSH), Argo Group International Holdings, Ltd. (NYSE - ARGO), Cardiovascular Systems, Inc. (Nasdaq – CSII)
February 14, 2023
From
Brodsky & Smith LLC
Via
GlobeNewswire
Better Buy: Johnson & Johnson or AbbVie?
February 14, 2023
The healthcare giants are favored by income-oriented investors but have a potentially disruptive year ahead.
Via
The Motley Fool
Candy? Flowers? These Top Stocks Offer You Something Even Sweeter
February 14, 2023
These stocks may reward you over time.
Via
The Motley Fool
The 7 Most Undervalued Dividend Aristocrats to Buy
February 13, 2023
With so many uncertainties ahead, investors may take comfort in the stability of the most undervalued dividend aristocrats to buy.
Via
InvestorPlace
Abbott-Cardiovascular Systems Acquisition Could Further Add Uncertainty Over Surmodics' Product: Analyst Downgrades Stock
February 13, 2023
Via
Benzinga
Cardiovascular Systems (NASDAQ: CSII) Enters Into Agreement to be Acquired By Abbott Labs (NYSE: ABT) For $890 Million
February 09, 2023
Cardiovascular Systems, Inc. (NASDAQ: CSII) is engaged as a medical device company, which is focused on the research, development and
Via
Spotlight Growth
Why Is Cardiovascular Systems (CSII) Stock Up 48% Today?
February 09, 2023
Cardiovascular Systems (CSII) stock is rising higher on Thursday following news that Abbott (ABT) intends to acquire the company.
Via
InvestorPlace
Abbott Adds Complementary Technologies To Its Vascular Offering Via Cardiovascular Systems Deal For $890M
February 09, 2023
Via
Benzinga
3 Dividend Stocks That Will Hold Up No Matter the Market Conditions
February 08, 2023
These stocks could boost your portfolio in bear markets and bull markets.
Via
The Motley Fool
Baby Formula Blues Hit Abbott Laboratories Stock Hard in 2022. Can It Rebound in 2023?
February 07, 2023
The healthcare stock fell 22% last year.
Via
The Motley Fool
< Previous
1
2
...
14
15
16
17
18
19
20
21
22
...
38
39
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.